Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 09, 2023 | |
Cover [Abstract] | ||
Entity Central Index Key | 0000105418 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Current Fiscal Year End Date | --12-31 | |
Document Transition Report | false | |
Entity File Number | 1-5039 | |
Entity Registrant Name | WEIS MARKETS, INC | |
Entity Incorporation, State or Country Code | PA | |
Entity Tax Identification Number | 24-0755415 | |
Entity Address, Address Line One | 1000 S. Second Street | |
Entity Address, Address Line Two | P. O. Box 471 | |
Entity Address, City or Town | Sunbury | |
Entity Address, State or Province | PA | |
Entity Address, Postal Zip Code | 17801-0471 | |
City Area Code | 570 | |
Local Phone Number | 286-4571 | |
Title of 12(b) Security | Common stock, no par value | |
Trading Symbol | WMK | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 26,898,443 | |
Amendment Flag | false | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2023 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Current: | ||
Cash and cash equivalents | $ 64,291 | $ 157,997 |
Marketable securities | 219,718 | 186,419 |
SERP investment | 24,131 | 22,696 |
Accounts receivable, net | 64,509 | 50,863 |
Inventories | 303,724 | 293,274 |
Prepaid expenses and other current assets | 42,617 | 29,921 |
Total current assets | 718,989 | 741,170 |
Property and equipment, net | 963,295 | 970,913 |
Operating lease right-to-use | 181,355 | 175,952 |
Goodwill | 52,330 | 52,330 |
Intangible and other assets, net | 18,850 | 18,785 |
Total assets | 1,934,819 | 1,959,150 |
Current: | ||
Accounts payable | 144,725 | 206,849 |
Accrued expenses | 37,987 | 57,431 |
Operating leases | 38,563 | 43,527 |
Accrued self-insurance | 17,159 | 19,416 |
Deferred revenue, net | 8,915 | 11,774 |
Income taxes payable | 6,436 | 6,354 |
Total current liabilities | 253,786 | 345,351 |
Postretirement benefit obligations | 26,317 | 25,270 |
Accrued self-insurance | 23,547 | 23,712 |
Operating leases | 148,344 | 142,424 |
Deferred income taxes | 115,938 | 111,225 |
Other | 8,570 | 9,334 |
Total liabilities | 576,503 | 657,316 |
Shareholders' Equity | ||
Common stock, no par value, 100,800,000 shares authorized, 33,047,807 shares issued, 26,898,443 shares outstanding | 9,949 | 9,949 |
Retained earnings | 1,505,060 | 1,449,191 |
Accumulated other comprehensive income (loss) (Net of deferred taxes of $2,105 in 2023 and $2,342 in 2022) | (5,836) | (6,449) |
Shareholders' equity before treasury stock | 1,509,173 | 1,452,691 |
Treasury stock at cost, 6,149,364 shares | (150,857) | (150,857) |
Total shareholders' equity | 1,358,316 | 1,301,834 |
Total liabilities and shareholders' equity | $ 1,934,819 | $ 1,959,150 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Common stock, par value | ||
Common stock, shares authorized | 100,800,000 | 100,800,000 |
Common stock, shares issued | 33,047,807 | 33,047,807 |
Common stock, shares outstanding | 26,898,443 | 26,898,443 |
Accumulated other comprehensive income, deferred taxes | $ 2,105 | $ 2,342 |
Treasury stock, shares | 6,149,364 |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Income Statement [Abstract] | ||||
Net sales | $ 1,160,306 | $ 1,150,551 | $ 3,483,975 | $ 3,389,853 |
Cost of sales, including advertising, warehousing and distribution expenses | 874,583 | 862,908 | 2,613,417 | 2,516,311 |
Gross profit on sales | 285,723 | 287,643 | 870,558 | 873,542 |
Operating, general and administrative expenses | 256,050 | 253,985 | 762,644 | 750,066 |
Income from operations | 29,673 | 33,658 | 107,914 | 123,476 |
Investment income (loss) and interest expense | 1,409 | (1,483) | 7,715 | (3,394) |
Other income (expense) | 774 | 1,214 | (1,399) | 4,805 |
Income before provision for income taxes | 31,856 | 33,389 | 114,230 | 124,887 |
Provision for income taxes | 8,630 | 4,731 | 30,925 | 28,574 |
Net income | $ 23,226 | $ 28,658 | $ 83,305 | $ 96,313 |
Weighted-average shares outstanding, basic | 26,898,443 | 26,898,443 | 26,898,443 | 26,898,443 |
Weighted-average shares outstanding, diluted | 26,898,443 | 26,898,443 | 26,898,443 | 26,898,443 |
Cash dividends per share | $ 0.34 | $ 0.32 | $ 1.02 | $ 0.96 |
Basic earnings per share | 0.86 | 1.07 | 3.10 | 3.58 |
Diluted earnings per share | $ 0.86 | $ 1.07 | $ 3.10 | $ 3.58 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 23,226 | $ 28,658 | $ 83,305 | $ 96,313 |
Available-for-sale marketable securities | ||||
Unrealized holding gains (losses) arising during period (Net of deferred taxes of $347 and $547, respectively for the thirteen weeks ended, and $237 and $3,370, respectively for the twenty-six weeks ended) | (962) | (2,023) | 613 | (9,143) |
Other comprehensive income gain (loss), net of tax | (962) | (2,023) | 613 | (9,143) |
Comprehensive income, net of tax | $ 22,264 | $ 26,635 | $ 83,918 | $ 87,170 |
Consolidated Statements of Co_2
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Unrealized holding gains (losses) arising during period, deferred taxes | $ 347 | $ 547 | $ 237 | $ 3,370 |
Consolidated Statements of Shar
Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands | Common Stock [Member] | Retained Earnings [Member] | AOCI Attributable to Parent [Member] | Treasury Stock, Common [Member] | Total |
Accumulated other comprehensive income (loss) balance, Beginning at Dec. 25, 2021 | $ 9,949 | $ 1,358,963 | $ 1,687 | $ (150,857) | $ 1,219,742 |
Balance, shares at Dec. 25, 2021 | 33,047,807 | ||||
Balance, treasury shares at Dec. 25, 2021 | 6,149,364 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 96,313 | 96,313 | |||
Other comprehensive income (loss), net of tax | (9,143) | (9,143) | |||
Dividends paid | (25,823) | (25,823) | |||
Accumulated other comprehensive income (loss) balance, Ending at Sep. 24, 2022 | $ 9,949 | 1,429,453 | (7,456) | $ (150,857) | 1,281,089 |
Balance, shares at Sep. 24, 2022 | 33,047,807 | ||||
Balance, treasury shares at Sep. 24, 2022 | 6,149,364 | ||||
Accumulated other comprehensive income (loss) balance, Beginning at Jun. 25, 2022 | $ 9,949 | 1,409,403 | (5,433) | $ (150,857) | 1,263,062 |
Balance, shares at Jun. 25, 2022 | 33,047,807 | ||||
Balance, treasury shares at Jun. 25, 2022 | 6,149,364 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 28,658 | 28,658 | |||
Other comprehensive income (loss), net of tax | (2,023) | (2,023) | |||
Dividends paid | (8,608) | (8,608) | |||
Accumulated other comprehensive income (loss) balance, Ending at Sep. 24, 2022 | $ 9,949 | 1,429,453 | (7,456) | $ (150,857) | 1,281,089 |
Balance, shares at Sep. 24, 2022 | 33,047,807 | ||||
Balance, treasury shares at Sep. 24, 2022 | 6,149,364 | ||||
Accumulated other comprehensive income (loss) balance, Beginning at Dec. 31, 2022 | $ 9,949 | 1,449,191 | (6,449) | $ (150,857) | $ 1,301,834 |
Balance, shares at Dec. 31, 2022 | 33,047,807 | 26,898,443 | |||
Balance, treasury shares at Dec. 31, 2022 | 6,149,364 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 83,305 | $ 83,305 | |||
Other comprehensive income (loss), net of tax | 613 | 613 | |||
Dividends paid | (27,436) | (27,436) | |||
Accumulated other comprehensive income (loss) balance, Ending at Sep. 30, 2023 | $ 9,949 | 1,505,060 | (5,836) | $ (150,857) | $ 1,358,316 |
Balance, shares at Sep. 30, 2023 | 33,047,807 | 26,898,443 | |||
Balance, treasury shares at Sep. 30, 2023 | 6,149,364 | 6,149,364 | |||
Accumulated other comprehensive income (loss) balance, Beginning at Jul. 01, 2023 | $ 9,949 | 1,490,979 | (4,874) | $ (150,857) | $ 1,345,198 |
Balance, shares at Jul. 01, 2023 | 33,047,807 | ||||
Balance, treasury shares at Jul. 01, 2023 | 6,149,364 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 23,226 | 23,226 | |||
Other comprehensive income (loss), net of tax | (962) | (962) | |||
Dividends paid | (9,145) | (9,145) | |||
Accumulated other comprehensive income (loss) balance, Ending at Sep. 30, 2023 | $ 9,949 | $ 1,505,060 | $ (5,836) | $ (150,857) | $ 1,358,316 |
Balance, shares at Sep. 30, 2023 | 33,047,807 | 26,898,443 | |||
Balance, treasury shares at Sep. 30, 2023 | 6,149,364 | 6,149,364 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 24, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 83,305 | $ 96,313 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 81,533 | 77,604 |
(Gain) loss on disposition of fixed assets | 5 | (2,481) |
Unrealized (gain) loss in value of equity securities | 815 | 1,590 |
Deferred income taxes | 4,476 | (1,711) |
Unrealized (gain) loss in SERP | (1,222) | 6,082 |
Changes in operating assets and liabilities: | ||
Inventories | (10,450) | (30,499) |
Accounts receivable and prepaid expenses | (26,342) | (3,689) |
Accounts payable and other liabilities | (89,437) | (9,802) |
Income taxes | 81 | 9,248 |
Other | 359 | (344) |
Net cash provided by operating activities | 43,125 | 142,311 |
Cash flows from investing activities: | ||
Purchase of property and equipment | (75,645) | (83,335) |
Proceeds from the sale of property and equipment | 336 | 6,710 |
Purchase of marketable securities | (92,569) | (267,106) |
Proceeds from the sale and maturities of marketable securities | 58,725 | 287,124 |
Purchase of intangible assets | (29) | (944) |
Proceeds from sale of intangible assets | 125 | |
Change in SERP investment | (213) | (507) |
Net cash used in investing activities | (109,394) | (57,933) |
Cash flows from financing activities: | ||
Dividends paid | (27,436) | (25,823) |
Net cash used in financing activities | (27,436) | (25,823) |
Net increase (decrease) in cash and cash equivalents | (93,706) | 58,555 |
Cash and cash equivalents at beginning of year | 157,997 | 86,048 |
Cash and cash equivalents at end of period | $ 64,291 | $ 144,603 |
Consolidated Statements of Ca_2
Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 24, 2022 | |
Statement of Cash Flows [Abstract] | ||
Income taxes paid | $ 26,400 | $ 21,700 |
Interest paid | $ 25 | $ 24 |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | (1) Significant Accounting Policies Basis of Presentation: The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring deferrals and accruals) considered necessary for a fair presentation have been included. The operating results for the periods presented are not necessarily indicative of the results to be expected for the full year. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited consolidated interim financial statements and there were no material subsequent events which require additional disclosure. For further information, refer to the Consolidated Financial Statements and footnotes thereto included in the Company’s latest Annual Report on Form 10-K. |
Current Relevant Accounting Sta
Current Relevant Accounting Standards | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
Current Relevant Accounting Standards | (2) Current Relevant Accounting Standards The Company regularly monitors recently issued accounting standards and assesses their applicability and impact. The Company believes that there are no accounting standard updates that have or will have a material or significant impact on the Company’s accounting policies. |
Marketable Securities
Marketable Securities | 9 Months Ended |
Sep. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Marketable Securities | (3) Marketable Securities The Company’s marketable securities are all classified as available-for-sale within “Current Assets” in the Company’s Consolidated Balance Sheets. FASB has established three levels of inputs that may be used to measure fair value: Level 1 Level 2 Level 3 The Company’s marketable securities valued using Level 1 inputs include highly liquid equity securities, for which quoted market prices are available. The Company’s bond and commercial paper portfolio is valued using a combination of pricing for similar securities, recently executed transactions, cash flow models with yield curves and other pricing models utilizing observable inputs, which are considered Level 2 inputs. For Level 2 investment valuation, the Company utilizes standard pricing procedures of its investment advisory firm which includes various third-party pricing services. These procedures also require specific price monitoring practices as well as pricing review reports, valuation oversight and pricing challenge procedures to maintain the most accurate representation of investment fair market value. The Company accrues interest on its bond and commercial paper portfolio throughout the life of each bond and commercial paper held. Dividends from the equity securities are recognized as received. Interest, dividends and unrealized gains and losses on equity securities are recognized in “Investment income (loss) and interest expense” on the Company’s Consolidated Statements of Income. The Company recognized investment gain of $2.2 million in the thirteen weeks ended September 30, 2023, which included an unrealized loss in equity securities of $437 thousand. In the thirteen weeks ended September 24, 2022, the Company recognized investment loss of $261 thousand, which included an unrealized loss in equity securities of $1.4 million. In the thirty-nine weeks ended September 30, 2023, the Company recognized investment income of $1.6 Marketable securities, as of September 30, 2023 and December 31, 2022, consisted of: Gross Gross (amounts in thousands) Amortized Unrealized Unrealized Fair September 30, 2023 Cost Holding Gains Holding Losses Value Available-for-sale: Level 1 Equity securities $ 4,370 Level 2 Corporate and municipal bonds $ 172,623 $ 1,609 $ (10,168) 164,063 Commercial Paper 50,666 618 — 51,285 Total $ 223,289 $ 2,227 $ (10,168) $ 219,718 Gross Gross (amounts in thousands) Amortized Unrealized Unrealized Fair December 31, 2022 Cost Holding Gains Holding Losses Value Available-for-sale: Level 1 Equity securities $ 5,185 Level 2 Corporate and municipal bonds $ 190,025 $ 2,110 $ (10,901) 181,234 Total $ 190,025 $ 2,110 $ (10,901) $ 186,419 Maturities of marketable securities classified as available-for-sale at September 30, 2023, were as follows: Amortized Fair (amounts in thousands) Cost Value Available-for-sale: Due within one year $ 88,980 $ 89,498 Due after one year through five years 83,664 79,256 Due after five years through ten years 17,957 15,904 Due after ten years 32,688 30,690 Total $ 223,289 $ 215,348 SERP Investments The Company also maintains a non-qualified supplemental executive retirement plan for certain of its associates which allows them to defer income to future periods. Participants in the plans earn a return on their deferrals based on mutual fund investments. The Company chooses to invest in the underlying mutual fund investments to offset the liability associated with the non-qualified deferred compensation plans. Such investments are reported on the Company’s Consolidated Balance Sheets as “SERP investment,” are classified as trading securities and are measured at fair value using Level 1 inputs with gains and losses included in “Investment income (loss) and interest expense” on the Company’s Consolidated Statements of Income. The Company recognized investment loss of $774 thousand in the thirteen weeks ended September 30, 2023, and investment loss of $1.2 million in the same period in 2022. The Company recognized investment income of million in the thirty-nine weeks ended September 30, 2023, and September 24, 2022, respectively. The changes in the underlying liability to the associates are recorded in “Other income (expense).” |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Income | (4) Accumulated Other Comprehensive Income All balances in accumulated other comprehensive income are related to available-for-sale marketable securities. The following table sets forth the balance of the Company’s accumulated other comprehensive income, net of tax. Unrealized Gains (Losses) on Available-for-Sale (amounts in thousands) Marketable Securities Accumulated other comprehensive income (loss) balance as of December 31, 2022 $ (6,449) Other comprehensive income (loss) 613 Net current period other comprehensive income (loss) 613 Accumulated other comprehensive income (loss) balance as of September 30, 2023 $ (5,836) |
Long-Term Debt
Long-Term Debt | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Long-Term Debt | (5) Long-Term Debt On September 1, 2016, Weis Markets entered into a revolving credit agreement with Wells Fargo Bank, N.A. (the “Credit Agreement”), which was amended on September 29, 2023, and matures on October 1, 2027. The Credit Agreement provides for an unsecured revolving credit facility with an aggregate principal amount not to exceed $30.0 million with an additional discretionary amount available of $70.0 million. As of September 30, 2023, the availability under the revolving credit agreement was $25.6 million, net of $4.4 million letters of credit. The letters of credit are maintained primarily to support performance, payment, deposit or surety obligations of the Company. Interest expense related to long-term debt was $8 thousand in each of the thirteen weeks ended September 30, 2023, and September 24, 2022. Interest expense related to long-term debt was $25 thousand and $24 thousand in the thirty-nine weeks ended September 30, 2023 and September 24, 2022, respectively. |
Revenue Recognition
Revenue Recognition | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | (6) Revenue Recognition The Chief Operating Officer, the Company’s chief operating decision maker, analyzes store operational revenues by geographical area but each area offers customers similar products, has similar distribution methods, and is supported by centralized management processes. The Company’s operations are reported as a single reportable segment. The following tables represent net sales by type of product for the thirteen and thirty-nine weeks ended September 30, 2023, and September 24, 2022: 13 Weeks Ended ( amounts in thousands September 30, 2023 September 24, 2022 Grocery $ 960,072 82.7 % $ 973,707 84.6 % Pharmacy 133,289 11.5 107,366 9.3 Fuel 64,524 5.6 66,350 5.8 Manufacturing 2,421 0.2 3,128 0.3 Total net sales $ 1,160,306 100.0 % $ 1,150,551 100.0 % 39 Weeks Ended ( amounts in thousands September 30, 2023 September 24, 2022 Grocery $ 2,915,444 83.7 % $ 2,867,699 84.5 % Pharmacy 380,917 10.9 317,564 9.4 Fuel 179,768 5.2 195,521 5.8 Manufacturing 7,846 0.2 9,069 0.3 Total net sales $ 3,483,975 100.0 % $ 3,389,853 100.0 % |
Leases
Leases | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Leases | (7) Leases As of September 30, 2023, the Company leased approximately 49% of its open store facilities under operating leases that expire at various dates through 2036, with the remaining store facilities being owned. These leases generally provide for fixed annual rentals; however, several provide for minimum annual rentals plus variable lease costs related to real estate taxes and insurance as well as contingent rentals based on a percentage of annual sales or increases periodically based on inflation. These variable lease costs are not included in the measurement of the operating lease right-to-use assets or lease liabilities and are charged to the related expense category included in “Operating, general and administrative expenses.” Most of the leases contain multiple renewal options, under which the Company may extend the lease terms from The Company leases or subleases space to tenants in owned, vacated and open store facilities. Rental income is recorded when earned as a component of “Operating, general and administrative expenses.” The following is a schedule of the lease costs included in “Operating, general and administrative expenses” for the thirteen and thirty-nine weeks ended September 30, 2023, and September 24, 2022. 13 Weeks Ended 39 Weeks Ended (amounts in thousands) September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Operating lease cost $ 11,778 $ 11,978 $ 35,351 $ 35,633 Variable lease cost 2,837 2,578 8,493 8,165 Lease or sublease income (2,649) (2,421) (7,755) (7,259) Net lease cost $ 11,966 $ 12,135 $ 36,089 $ 36,539 |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation: The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring deferrals and accruals) considered necessary for a fair presentation have been included. The operating results for the periods presented are not necessarily indicative of the results to be expected for the full year. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited consolidated interim financial statements and there were no material subsequent events which require additional disclosure. For further information, refer to the Consolidated Financial Statements and footnotes thereto included in the Company’s latest Annual Report on Form 10-K. |
Current Relevant Accounting Standards | The Company regularly monitors recently issued accounting standards and assesses their applicability and impact. The Company believes that there are no accounting standard updates that have or will have a material or significant impact on the Company’s accounting policies. |
Marketable Securities (Tables)
Marketable Securities (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule Of Marketable Securities | Gross Gross (amounts in thousands) Amortized Unrealized Unrealized Fair September 30, 2023 Cost Holding Gains Holding Losses Value Available-for-sale: Level 1 Equity securities $ 4,370 Level 2 Corporate and municipal bonds $ 172,623 $ 1,609 $ (10,168) 164,063 Commercial Paper 50,666 618 — 51,285 Total $ 223,289 $ 2,227 $ (10,168) $ 219,718 Gross Gross (amounts in thousands) Amortized Unrealized Unrealized Fair December 31, 2022 Cost Holding Gains Holding Losses Value Available-for-sale: Level 1 Equity securities $ 5,185 Level 2 Corporate and municipal bonds $ 190,025 $ 2,110 $ (10,901) 181,234 Total $ 190,025 $ 2,110 $ (10,901) $ 186,419 |
Schedule Of Maturities Of Marketable Securities | Amortized Fair (amounts in thousands) Cost Value Available-for-sale: Due within one year $ 88,980 $ 89,498 Due after one year through five years 83,664 79,256 Due after five years through ten years 17,957 15,904 Due after ten years 32,688 30,690 Total $ 223,289 $ 215,348 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Schedule Of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Available-for-Sale (amounts in thousands) Marketable Securities Accumulated other comprehensive income (loss) balance as of December 31, 2022 $ (6,449) Other comprehensive income (loss) 613 Net current period other comprehensive income (loss) 613 Accumulated other comprehensive income (loss) balance as of September 30, 2023 $ (5,836) |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule Of Sales By Type Of Product | 13 Weeks Ended ( amounts in thousands September 30, 2023 September 24, 2022 Grocery $ 960,072 82.7 % $ 973,707 84.6 % Pharmacy 133,289 11.5 107,366 9.3 Fuel 64,524 5.6 66,350 5.8 Manufacturing 2,421 0.2 3,128 0.3 Total net sales $ 1,160,306 100.0 % $ 1,150,551 100.0 % 39 Weeks Ended ( amounts in thousands September 30, 2023 September 24, 2022 Grocery $ 2,915,444 83.7 % $ 2,867,699 84.5 % Pharmacy 380,917 10.9 317,564 9.4 Fuel 179,768 5.2 195,521 5.8 Manufacturing 7,846 0.2 9,069 0.3 Total net sales $ 3,483,975 100.0 % $ 3,389,853 100.0 % |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Schedule of Lease Costs | 13 Weeks Ended 39 Weeks Ended (amounts in thousands) September 30, 2023 September 24, 2022 September 30, 2023 September 24, 2022 Operating lease cost $ 11,778 $ 11,978 $ 35,351 $ 35,633 Variable lease cost 2,837 2,578 8,493 8,165 Lease or sublease income (2,649) (2,421) (7,755) (7,259) Net lease cost $ 11,966 $ 12,135 $ 36,089 $ 36,539 |
Marketable Securities - Investm
Marketable Securities - Investment Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Investment Income, Net [Abstract] | ||||
Investment income (loss) | $ 2,200 | $ 261 | $ 6,300 | $ 1,400 |
Equity Securities, FV-NI, Unrealized Gain (Loss) [Abstract] | ||||
Unrealized gain (loss) on equity securities | $ 437 | $ 1,400 | $ (815) | $ (1,590) |
Marketable Securities - Fair Va
Marketable Securities - Fair Value (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Marketable Securities [Abstract] | ||
Equity securities | $ 4,370 | $ 5,185 |
Available-for-sale securities | 215,348 | |
Marketable securities | $ 219,718 | $ 186,419 |
Equity Securities, FV-NI, Fair Value by Fair Value Hierarchy Level | us-gaap:FairValueInputsLevel1Member | us-gaap:FairValueInputsLevel1Member |
Bonds [Member] | ||
Marketable Securities [Abstract] | ||
Available-for-sale securities | $ 164,063 | $ 181,234 |
Debt Securities, Available-for-Sale, Fair Value by Fair Value Hierarchy Level | us-gaap:FairValueInputsLevel2Member | us-gaap:FairValueInputsLevel2Member |
Commercial Paper [Member] | ||
Marketable Securities [Abstract] | ||
Available-for-sale securities | $ 51,285 | |
Debt Securities, Available-for-Sale, Fair Value by Fair Value Hierarchy Level | us-gaap:FairValueInputsLevel2Member |
Marketable Securities - Amortiz
Marketable Securities - Amortized Cost (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract] | ||
Amortized Cost | $ 223,289 | $ 190,025 |
Gross Unrealized Holding Gains | 2,227 | 2,110 |
Gross Unrealized Holding Losses | (10,168) | (10,901) |
Fair Value | 215,348 | |
Bonds [Member] | ||
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract] | ||
Amortized Cost | 172,623 | 190,025 |
Gross Unrealized Holding Gains | 1,609 | 2,110 |
Gross Unrealized Holding Losses | (10,168) | (10,901) |
Fair Value | 164,063 | $ 181,234 |
Commercial Paper [Member] | ||
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract] | ||
Amortized Cost | 50,666 | |
Gross Unrealized Holding Gains | 618 | |
Fair Value | $ 51,285 |
Marketable Securities - Maturit
Marketable Securities - Maturities (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract] | ||
Amortized Cost, Due within one year | $ 88,980 | |
Amortized Cost, Due after one year through five years | 83,664 | |
Amortized Cost, Due after five years through ten years | 17,957 | |
Amortized Cost, Due after ten years | 32,688 | |
Amortized Cost | 223,289 | $ 190,025 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling Maturity, Fair Value [Abstract] | ||
Fair Value, Due within one year | 89,498 | |
Fair Value, Due after one year through five years | 79,256 | |
Fair Value, Due after five years through ten years | 15,904 | |
Fair Value, Due after ten years | 30,690 | |
Fair Value | $ 215,348 |
Marketable Securities - SERP In
Marketable Securities - SERP Investments (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Net Investment Income [Line Items] | ||||
Investment Income (Loss) and Interest Expense | $ 1,409 | $ (1,483) | $ 7,715 | $ (3,394) |
Supplemental Employee Retirement Plan [Member] | ||||
Net Investment Income [Line Items] | ||||
Investment Income (Loss) and Interest Expense | $ 774 | $ 1,200 | $ 1,400 | $ 4,800 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Accumulated other comprehensive income (loss) balance, Beginning | $ 1,345,198 | $ 1,263,062 | $ 1,301,834 | $ 1,219,742 |
Other comprehensive income gain (loss), net of tax | (962) | (2,023) | 613 | (9,143) |
Accumulated other comprehensive income (loss) balance, Ending | 1,358,316 | 1,281,089 | 1,358,316 | 1,281,089 |
AOCI Attributable to Parent [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Accumulated other comprehensive income (loss) balance, Beginning | (4,874) | (5,433) | (6,449) | 1,687 |
Accumulated other comprehensive income (loss) balance, Ending | (5,836) | $ (7,456) | (5,836) | $ (7,456) |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Accumulated other comprehensive income (loss) balance, Beginning | (6,449) | |||
Other comprehensive income (loss) | 613 | |||
Other comprehensive income gain (loss), net of tax | 613 | |||
Accumulated other comprehensive income (loss) balance, Ending | $ (5,836) | $ (5,836) |
Long-Term Debt - General Inform
Long-Term Debt - General Information (Details) | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Revolving Credit Agreement, Wells Fargo Bank, National Association [Member] | Revolving Credit Facility [Member] | |
Debt Instrument [Line Items] | |
Debt Instrument, Issuance Date | Sep. 01, 2016 |
Debt Instrument, Maturity Date | Oct. 01, 2027 |
Line of Credit Facility, Remaining Borrowing Capacity | $ 25,600,000 |
Revolving Credit Agreement, Wells Fargo Bank, National Association, Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | |
Debt Instrument [Line Items] | |
Line of Credit Facility, Maximum Borrowing Capacity | 30,000,000 |
Revolving Credit Agreement, Wells Fargo Bank, National Association, Revolving Credit Facility, Discretionary [Member] | Line of Credit [Member] | |
Debt Instrument [Line Items] | |
Line of Credit Facility, Maximum Borrowing Capacity | 70,000,000 |
Revolving Credit Agreement, Wells Fargo Bank, National Association, Letters of Credit [Member] | Letter of Credit [Member] | |
Debt Instrument [Line Items] | |
Amount of facility borrowed | $ 4,400,000 |
Long-Term Debt - Interest Expen
Long-Term Debt - Interest Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2023 | Sep. 24, 2022 | |
Interest Expense, Debt [Abstract] | |||
Interest expense | $ 8 | $ 25 | $ 24 |
Revenue Recognition - Segments
Revenue Recognition - Segments (Details) - segment | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract] | ||||
Number of reportable segments | 1 | 1 | 1 | 1 |
Revenue Recognition - Revenue b
Revenue Recognition - Revenue by Product (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Total net sales | $ 1,160,306 | $ 1,150,551 | $ 3,483,975 | $ 3,389,853 |
Grocery [Member] | ||||
Disaggregation of Revenue [Line Items] | ||||
Total net sales | 960,072 | 973,707 | 2,915,444 | 2,867,699 |
Pharmacy [Member] | ||||
Disaggregation of Revenue [Line Items] | ||||
Total net sales | 133,289 | 107,366 | 380,917 | 317,564 |
Fuel, Product [Member] | ||||
Disaggregation of Revenue [Line Items] | ||||
Total net sales | 64,524 | 66,350 | 179,768 | 195,521 |
Manufacturing [Member] | ||||
Disaggregation of Revenue [Line Items] | ||||
Total net sales | $ 2,421 | $ 3,128 | $ 7,846 | $ 9,069 |
Revenue Recognition - Concentra
Revenue Recognition - Concentration Risk (Details) - Revenue from Contract with Customer Benchmark [Member] - Product Concentration Risk [Member] | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Product Information [Line Items] | ||||
Concentration risk (as a percent) | 100% | 100% | 100% | 100% |
Grocery [Member] | ||||
Product Information [Line Items] | ||||
Concentration risk (as a percent) | 82.70% | 84.60% | 83.70% | 84.50% |
Pharmacy [Member] | ||||
Product Information [Line Items] | ||||
Concentration risk (as a percent) | 11.50% | 9.30% | 10.90% | 9.40% |
Fuel, Product [Member] | ||||
Product Information [Line Items] | ||||
Concentration risk (as a percent) | 5.60% | 5.80% | 5.20% | 5.80% |
Manufacturing [Member] | ||||
Product Information [Line Items] | ||||
Concentration risk (as a percent) | 0.20% | 0.30% | 0.20% | 0.30% |
Leases - General Information (D
Leases - General Information (Details) | Sep. 30, 2023 |
Lessee, Operating Lease, Description [Abstract] | |
Percentage of facilities under operating leases | 49% |
Maximum [Member] | |
Lessee, Operating Lease, Description [Abstract] | |
Lease renewal term | 20 years |
Minimum [Member] | |
Lessee, Operating Lease, Description [Abstract] | |
Lease renewal term | 5 years |
Leases - Lease Costs (Details)
Leases - Lease Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Lease, Cost [Abstract] | ||||
Operating lease cost | $ 11,778 | $ 11,978 | $ 35,351 | $ 35,633 |
Variable lease cost | 2,837 | 2,578 | 8,493 | 8,165 |
Lease or sublease income | (2,649) | (2,421) | (7,755) | (7,259) |
Net lease cost | $ 11,966 | $ 12,135 | $ 36,089 | $ 36,539 |